Plitidepsin (Aplidin) is a potent inhibitor of diffuse large cell and Burkitt lymphoma and is synergistic with rituximab

Plitidepsin (Aplidin), an antitumor agent of marine origin, presently is undergoing phase II/III clinical trials, and has shown promise for the treatment of lymphoma. Here, we describe the antitumor effects of plitidepsin alone and in combination with rituximab and investigated the effects of each d...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Barboza, Nora M, Medina, Daniel J, Budak-Alpdogan, Tulin, Aracil, Miguel, Jimeno, José M, Bertino, Joseph R, Banerjee, Debabrata
Формат: Artigo
Язык:Inglês
Опубликовано: Landes Bioscience 2012
Предметы:
Research Paper
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3336068/
https://ncbi.nlm.nih.gov/pubmed/22336911
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/cbt.13.2.18876
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы